Primary Peptides

Peptide Therapeutics

PP-003 RD Parkinson's; PP-007 RD Neurodegeneration; PP-008 RD neuromuscular

Primary Peptides is using protein manipulation to create new therapeutics. By combining neuroscience and proteome informatics with computational strategies, Primary Peptides is designing therapeutic interventions that are not amenable to current small molecules and antibodies. The protein manipulation approaches that Primary Peptides is exploring include: [1] protein-protein interaction blockade to prevent disease-causing proteins interacting, [2] protein stabilization and [3] protein degradation. Through these platforms, Primary Peptides is advancing clinical and preclinical therapeutic candidates with their lead compound, K13, in early clinical stages for neuroprotection in acute stroke.

Jobs:

News: